A secure blood-saving protocol for Jehovah’s Witnesses in primary total hip replacement
Joint Diseases and Related Surgery · 2024
DOI: 10.52312/jdrs.2023.1272 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Joint Diseases and Related Surgery, 2024. Verfasst von Mustafa Fatih Dasci und 6 weiteren Autor:innen. Beteiligte Einrichtung: ENDO-Klinik Hamburg Department of Orthopaedic Surgery Holstenstr. 2, 22767 Hamburg, Germany. mcitak@gmx.de. Hauptthemen laut MEDLINE: Jehovah's Witnesses, Arthroplasty, Replacement, Hip, Operative Blood Salvage, Tranexamic Acid. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
OBJECTIVES: The study aimed to analyze the efficacy of the blood management protocol developed by our team for patients who are Jehovah's Witnesses (JW) presenting for primary total hip replacement (THR). PATIENTS AND METHODS: Thirty JW patients (6 males, 24 females; mean age: 70.1±9.8 years; range, 65 to 81 years) and 30 age- and sex-matched controls (6 males, 24 females; mean age: 68.7±9.1 years; range, 62 to 79 years) who underwent primary THR at our institution between January 2018 and June 2020 were retrospectively evaluated. While the surgical technique of THR was not different among the groups, blood loss management differed between the groups. Patients in the control group were given 1 g of intravenous tranexamic acid (TXA) 15 min before the surgical incision. In addition to the same TXA protocol, intraoperative cell salvage with a continuous autologous transfusion system was used for JW patients. The estimated blood loss (EBL) was determined using Meunier's formula. Hemoglobin (Hgb) decline, EBL on the first and third postoperative days, allogenic blood transfusion (ABT) requirement, and complications were analyzed between groups. RESULTS: There were no significant differences between groups regarding demographic and clinical characteristics (p>0.05), ABT requirement (p>0.999), and Hgb decline in the first and third postoperative days (p=0.540 and p=0.836, respectively). Furthermore, both groups did not significantly differ between EBL in the first and third postoperative days (p=0.396 and p=0.616, respectively) and the length of hospital stay (p=0.547). Similar complication rates were noted for both groups. Hemoglobin level assessments revealed that values on the first and third postoperative days were significantly lower than the baseline Hgb value in both cohorts (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- ENDO-Klinik Hamburg Department of Orthopaedic Surgery Holstenstr. 2, 22767 Hamburg, Germany. mcitak@gmx.de.
Zitieren
APA
Dasci, M. F., Kose, O., Maza, B. F., Gozacan, B., Sandiford, N. A., Gehrke, T., & Citak, M. (2024). A secure blood-saving protocol for Jehovah’s Witnesses in primary total hip replacement. Joint Diseases and Related Surgery. https://doi.org/10.52312/jdrs.2023.1272
Vancouver
Dasci MF, Kose O, Maza BF, Gozacan B, Sandiford NA, Gehrke T, et al. A secure blood-saving protocol for Jehovah’s Witnesses in primary total hip replacement. Joint Diseases and Related Surgery. 2024. doi:10.52312/jdrs.2023.1272
BibTeX
@article{Dasci2024,
author = {Dasci, Mustafa Fatih and Kose, Ozkan and Maza, Beatriz Fernandez and Gozacan, Beren and Sandiford, N Amir and Gehrke, Thorsten and Citak, Mustafa},
title = {A secure blood-saving protocol for Jehovah’s Witnesses in primary total hip replacement},
journal = {Joint Diseases and Related Surgery},
year = {2024},
doi = {10.52312/jdrs.2023.1272}
}
EUVIMED